The Prostate Imaging Quality (PI-QUAL) V2 is a simplified update of PI-QUAL V1 for assessing image quality in multiparametric prostate MRI (mpMRI), aimed at improving clinical use and reproducibility.

Add Yahoo as a preferred source to see more of our stories on Google. EDITOR’S NOTE: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the ...

Stockholm3-MRI population-based screening: Two-year outcomes comparing Stockholm3 and PSA. Predictive capability of combining ExoDx (EPI) and pre-biopsy prostate MRI in detecting clinically ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Using both PSMA PET and mpMRI before cognitive targeted biopsy improved specificity for clinically significant prostate cancer from 54.6% to 86.3%. For men undergoing evaluation for suspected prostate ...

The UK NSC recently ruled against population-wide testing, but experts fear the decision could have serious consequences for ...

The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer. Multivariable logistic regression model for predicting ...

A new comprehensive review suggests that screening men for prostate cancer using a blood test could reduce deaths from the disease, though experts continue to highlight significant risks associated ...

Experts are urging officials to rethink their decision on prostate cancer screening, after an MRI approach was shown to slash ...

EDITOR’S NOTE: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. When I learned that ...